课题基金 / 基金详情

Improving Maternal and Child Health in the Year After Birth: An Early Evaluation of Postpartum Medicaid Eligibility Extensions

Improving Maternal and Child Health in the Year After Birth: An Early Evaluation of Postpartum Medicaid Eligibility Extensions
改善产后一年内的母婴健康:产后医疗补助资格延期的早期评估
批准号:
10705790
负责人:
Lindsay Kennedy Admon
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-07-31

项目摘要

项目成果

Lindsay Kennedy Admon的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY State Medicaid programs pay for nearly half of all births in the United States (U.S.), financing over 1.6 million births in 2019. Federal law requires states to provide pregnancy-related Medicaid coverage to low-income pregnant individuals through 60 days postpartum, after which 1 in 4 become uninsured. A substantial and increasing proportion of adverse pregnancy-related outcomes, including maternal morbidity and mortality, are occurring among individuals with Medicaid-paid births and after pregnancy-related Medicaid coverage ends. Postpartum Medicaid eligibility extensions (PMEs) to one year postpartum are an emerging strategy for improving insurance enrollment, healthcare access, and health for low-income mothers and children. Passed in response to the COVID-19 Public Health Emergency, two federal laws have accelerated implementation of PMEs. First, the Families First Coronavirus Response Act (FFCRA) of March 2020 prevented states from disenrolling Medicaid beneficiaries during the public health emergency. In turn, the FFCRA created a national de facto PME. Second, the American Rescue Plan Act (ARPA) of March 2021 allows states to adopt PMEs starting in April 2022 with federal matching funds. Rigorous evaluations of these policies are urgently needed to inform state decisions to adopt PMEs and determine whether these polices are having the intended effect of improving maternal, child, and pregnancy-related health in the year after birth. To inform ongoing, evidence-based policymaking and fill this significant gap in maternal and child health research, our multi-disciplinary team will conduct rigorous, quasi-experimental evaluations that exploit state variation in policy adoption to provide timely data on the FFCRA and ARPA and associated changes in 1) maternal insurance enrollment, healthcare use, and health; 2) children’s insurance enrollment, healthcare use, and health; and 3) outcomes among subsequent pregnancies including rates of short interpregnancy interval and preterm births (NOT-HS-14-004). Given that a disproportionate share of those with Medicaid-paid births and experiencing adverse health events in the postpartum year are low-income and Black, Indigenous, or people of color (AHRQ priority populations), we will also measure the impact of PMEs on racial health equity (NOT-HS-21-014). The proposed set of evaluations will produce data directly informing whether these unprecedented, large-scale policy interventions have been associated with improvements in maternal and child health or racial and ethnic disparities in the year after birth. We will generate timely findings to inform ongoing, evidence-based policymaking to address the U.S. maternal health crisis. Ultimately, we aim to improve health and reduce disparities in the year after birth among low-income mothers and children at the population level.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1001/jamahealthforum.2023.4179
发表时间: 2023-11-03
期刊: JAMA HEALTH FORUM
影响因子: --
作者: [Daw, Jamie R., Yekta, Sarra, Jacobson-Davies, Faelan E., Patrick, Stephen W., Admon, Lindsay K.]
通讯作者: Admon, Lindsay K.
Improving Maternal and Child Health in the Year After Birth: An Early Evaluation of Postpartum Medicaid Eligibility Extensions
Understanding the impact of perinatal insurance disruptions on maternal and child health outcomes
Understanding the impact of perinatal insurance disruptions on maternal and child health outcomes
Understanding the impact of perinatal insurance disruptions on maternal and child health outcomes
国内基金
海外基金
果蝇Maternal Haploid 蛋白调控胚胎发育的分子机制研究
  • 批准号:
    31460299
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2014
  • 负责人:
    曹进国
  • 依托单位:
母猪母性杀婴(maternal infanticide)行为QTL精细定位及位置候选基因研究
  • 批准号:
    30760164
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2007
  • 负责人:
    陈从英
  • 依托单位: